Skip to main content
SpringerLink
Log in

Metabolic effects of carteolol and dilevalol in essential hypertension

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lardinois CK, Neuman SL (1988) The effects of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med 146: 1280–1288

    Google Scholar 

  2. Houston MC (1989) New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J 117: 911–951

    Google Scholar 

  3. Leren P, Foss PO, Helgeland A (1980) Effect of propranolol and prazosin on blood lipids: The Oslo Study. Lancet II: 4–6

    Google Scholar 

  4. Streja D, Mymin D (1978) Effect of propranolol on HDL cholesterol concentrations. Br Med J 2: 149

    Google Scholar 

  5. Ropuffy J, Jaillard J (1984) Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients. Am J Med 76 (2A): 105–108

    Google Scholar 

  6. Pasotti C, Capra A, Fiorella G (1982) Effects of pindolol and metoprolol on plasma lipids and lipoproteins. Br J Clin Pharmacol 13: 435s-439s

    Google Scholar 

  7. Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T, Kushida K (1983) Pharmacokinetics and absolute bioavailability of carteolol, a new β-adrenergic blocking agent. Eur J Clin Pharmacol 25: 95–101

    Google Scholar 

  8. Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T, Kushida K (1983) Concentration-effect and time-effect relationship of carteolol. Eur J Clin Pharmacol 25: 749–757

    Google Scholar 

  9. Sybertz EJ, Watkins RW (1989) Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta2 agonist-mediated vasodilation and beta antagonism. Am J Cardiol 63: 3i-6i

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan

    T. Baba, K. Takebe & T. Tomiyama

Authors
  1. T. Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Takebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Tomiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baba, T., Takebe, K. & Tomiyama, T. Metabolic effects of carteolol and dilevalol in essential hypertension. Eur J Clin Pharmacol 42, 117–118 (1992). https://doi.org/10.1007/BF00314932

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314932

Key words

Search

Navigation